T. Tan

1.2k total citations · 1 hit paper
32 papers, 787 citations indexed

About

T. Tan is a scholar working on Rheumatology, Cardiology and Cardiovascular Medicine and Infectious Diseases. According to data from OpenAlex, T. Tan has authored 32 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Infectious Diseases. Recurrent topics in T. Tan's work include Autoimmune and Inflammatory Disorders Research (5 papers), COVID-19 Clinical Research Studies (4 papers) and Cardiovascular Function and Risk Factors (4 papers). T. Tan is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (5 papers), COVID-19 Clinical Research Studies (4 papers) and Cardiovascular Function and Risk Factors (4 papers). T. Tan collaborates with scholars based in Singapore, Australia and United States. T. Tan's co-authors include Bernard Yu‐Hor Thong, David A. Karnofsky, M. Lois Murphy, Rose Ruth Ellison, Marguerite P. Sykes, Joseph H. Burchenal, C. P. Rhoads, Harold W. Dargeon, Louis A. Leone and Lloyd F. Craver and has published in prestigious journals such as Blood, Annals of the New York Academy of Sciences and European Heart Journal.

In The Last Decade

T. Tan

30 papers receiving 692 citations

Hit Papers

Clinical Evaluation of a New Antimetabolite, 6-Mercaptopu... 1953 2026 1977 2001 1953 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Tan Singapore 10 251 170 140 108 100 32 787
Pierre‐Dominique Ghislain Belgium 17 443 1.8× 64 0.4× 420 3.0× 106 1.0× 61 0.6× 36 1.5k
Siew Eng Choon Malaysia 20 379 1.5× 57 0.3× 233 1.7× 89 0.8× 74 0.7× 52 1.5k
Rebecca Pavlos Australia 15 607 2.4× 24 0.1× 229 1.6× 61 0.6× 55 0.6× 24 882
Monika Keller Switzerland 7 387 1.5× 31 0.2× 178 1.3× 28 0.3× 44 0.4× 9 737
P. de la Cueva Spain 22 41 0.2× 63 0.4× 188 1.3× 141 1.3× 63 0.6× 107 1.2k
Nami Shrestha Palikhe South Korea 19 209 0.8× 32 0.2× 114 0.8× 48 0.4× 49 0.5× 39 689
Nasrullah Undre United Kingdom 23 121 0.5× 179 1.1× 26 0.2× 733 6.8× 53 0.5× 69 1.8k
José Luis Aguilar United States 15 69 0.3× 58 0.3× 184 1.3× 43 0.4× 140 1.4× 46 1.0k
J Roujeau France 14 991 3.9× 76 0.4× 492 3.5× 79 0.7× 23 0.2× 52 1.4k
Francesco Locati Italy 7 910 3.6× 38 0.2× 445 3.2× 90 0.8× 21 0.2× 13 1.1k

Countries citing papers authored by T. Tan

Since Specialization
Citations

This map shows the geographic impact of T. Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Tan more than expected).

Fields of papers citing papers by T. Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Tan. The network helps show where T. Tan may publish in the future.

Co-authorship network of co-authors of T. Tan

This figure shows the co-authorship network connecting the top 25 collaborators of T. Tan. A scholar is included among the top collaborators of T. Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Tan. T. Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhat, A., E. Samson, David Chandrakumar, et al.. (2023). Impact of a Specialised AF Clinic on Unplanned AF-Related Rehospitalisation. Heart Lung and Circulation. 32. S198–S198. 1 indexed citations
2.
Leong, Khai Pang, et al.. (2022). Antiphospholipid and other autoantibodies in COVID-19 patients: A Singapore series. Annals of the Academy of Medicine Singapore. 51(9). 586–588. 1 indexed citations
3.
Santosa, Amelia, Chuanhui Xu, Thaschawee Arkachaisri, et al.. (2021). Recommendations for COVID‐19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists. International Journal of Rheumatic Diseases. 24(6). 746–757. 19 indexed citations
4.
Tan, T., et al.. (2021). Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms. International Journal of Infectious Diseases. 104. 363–369. 30 indexed citations
5.
Tan, T., et al.. (2020). Clinical utility of anti-DFS70 for identifying antinuclear antibody-positive patients without systemic autoimmune rheumatic disease. Singapore Medical Journal. 63(3). 147–151. 5 indexed citations
6.
Tan, T., et al.. (2020). Atypical presentation of Good syndrome: acute hepatitis from hepatitis B virus reactivation. Asia Pacific Allergy. 10(4). e37–e37. 3 indexed citations
7.
Bhat, A., David Chandrakumar, F. Fernandez, et al.. (2020). Key changes in indices of myocardial work in cardiometabolic disease states. European Heart Journal. 41(Supplement_2). 1 indexed citations
8.
Teng, Gim Gee, Peter Cheung, Warren Fong, et al.. (2019). Singapore chapter of rheumatologists' updated consensus statement on the eligibility for government subsidization of biologic and targeted therapy for the treatment of psoriatic arthritis. International Journal of Rheumatic Diseases. 23(2). 153–164. 1 indexed citations
9.
Leong, Wai Yie, Peter Cheung, Warren Fong, et al.. (2019). Singapore Chapter of Rheumatologists updated consensus statement on the eligibility for government subsidization of biologic and targeted‐synthetic therapy for the treatment of rheumatoid arthritis. International Journal of Rheumatic Diseases. 23(2). 140–152. 1 indexed citations
10.
Phang, Kee Fong, Manjari Lahiri, Warren Fong, et al.. (2019). Update on recommendations for eligibility of government subsidization of biologic disease‐modifying antirheumatic drugs for the treatment of axial spondyloarthritis in Singapore. International Journal of Rheumatic Diseases. 23(2). 165–173. 3 indexed citations
12.
Tan, T., et al.. (2019). Impact of an interstitial lung disease service in the diagnosis and management of interstitial lung disease in Singapore. Singapore Medical Journal. 61(6). 302–307. 6 indexed citations
13.
Thong, Bernard Yu‐Hor, et al.. (2018). Shellfish/crustacean oral allergy syndrome among national service pre-enlistees in Singapore. Asia Pacific Allergy. 8(2). e18–e18. 10 indexed citations
14.
Klimis, Harry, et al.. (2017). A Case of Persistent Right Ventricular Failure after Rapid Decompression of a Large Chronic Pericardial Effusion. Heart Lung and Circulation. 26. S241–S242. 3 indexed citations
15.
Bhat, A., et al.. (2017). An Uncommon Case of Cisplatin-Induced Non-Ischaemic Cardiomyopathy. Heart Lung and Circulation. 26. S128–S128.
16.
Thong, Bernard Yu‐Hor, et al.. (2014). A retrospective study on sequential desensitization-rechallenge for antituberculosis drug allergy. Asia Pacific Allergy. 4(3). 156–163. 29 indexed citations
17.
Thong, Bernard Yu‐Hor & T. Tan. (2010). Epidemiology and risk factors for drug allergy. British Journal of Clinical Pharmacology. 71(5). 684–700. 277 indexed citations
18.
Tan, T., et al.. (2005). Severe Upper Limb Complications from Parenteral Abuse of Subutex®. Annals of the Academy of Medicine Singapore. 34(9). 575–578. 17 indexed citations
19.
Tan, T., et al.. (2003). Carotid Artery Occlusion in a Patient with Intracranial Rosai-Dorfman Disease. 3 indexed citations
20.
Goh, L G, et al.. (1991). Using role-play to teach consultation skills—the Singapore experience. Medical Teacher. 13(1). 55–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026